Trial yields positive results for Lymphoseek

05/10/2009 | ScienceDaily

A Phase III study involving early-stage breast cancer patients showed that the radiopharmaceutical Lymphoseek can detect 100% of cancer-positive lymph nodes quicker and in a more convenient and targeted way than standard methods. "These results will really enable molecular biology to enter the operating room for lymph node detection," a researcher said.

View Full Article in:

ScienceDaily

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL